NYKODE THERAPEUTICS ASA earnings per share and revenue

5VB earnings per share for the last quarter are -0.04 EUR whereas the estimation was -0.04 EUR which accounts for 11.13% surprise. Company revenue for the same period amounts to 580.39 k EUR despite the estimated figure of 2.62 M EUR. Estimated earnings per share for the next quarter are -0.05 EUR, and revenue is expected to reach 1.28 M EUR. Also watch annual changes over time to get a bigger picture of 5VB earnings per share and revenue dynamics.